MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents ; volume:13 ; number:1 ; day:11 ; month:12 ; year:2020 ; pages:1-19 ; date:12.2020
Journal of hematology & oncology ; 13, Heft 1 (11.12.2020), 1-19, 12.2020
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Bolomsky, Arnold
Vogler, Meike
Köse, Murat Cem
Heckman, Caroline A.
Ehx, Grégory
Ludwig, Heinz
Caers, Jo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-020-01007-9
- URN
-
urn:nbn:de:101:1-2021011819265915986988
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bolomsky, Arnold
- Vogler, Meike
- Köse, Murat Cem
- Heckman, Caroline A.
- Ehx, Grégory
- Ludwig, Heinz
- Caers, Jo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Heterocyclic anticancer agents
mTOR inhibitors: A novel class of anti-cancer agents
Thiadiazole derivatives as anticancer agents
Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents
MCL.
MCXLI. - MCL.
Iridium compounds as prospective anti-cancer agents
Microcystins as Lead Structures for Anticancer Agents
Casus MCL - MCLV
Metallo-Drugs: development and action of anticancer agents
Recent updates on thienopyrimidine derivatives as anticancer agents
Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Heterocyclic anticancer agents
mTOR inhibitors: A novel class of anti-cancer agents
Thiadiazole derivatives as anticancer agents
Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents
MCL.
MCXLI. - MCL.
Iridium compounds as prospective anti-cancer agents
Microcystins as Lead Structures for Anticancer Agents
Casus MCL - MCLV
Metallo-Drugs: development and action of anticancer agents
Recent updates on thienopyrimidine derivatives as anticancer agents
Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Heterocyclic anticancer agents
mTOR inhibitors: A novel class of anti-cancer agents
Thiadiazole derivatives as anticancer agents
Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents
MCL.
MCXLI. - MCL.
Iridium compounds as prospective anti-cancer agents
Microcystins as Lead Structures for Anticancer Agents
Casus MCL - MCLV
Metallo-Drugs: development and action of anticancer agents